They are growth-hormone secretagogues that should be understood as investigational research peptides they have not gone through the approval process that establishes safety and efficacy for a defined clinical use
Summary: B12 injections do not promote fat loss in individuals with normal vitamin B12 levels and are not clinically indicated for weight management purposes
Consequently, individuals undergoing Sermorelin therapy often experience weight loss and favorable changes in body composition, reducing body fat percentage
Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis
Singh, R., Barden, A., Mori, T
Individual plots from different studies are shown in Figure 3D